Stock listing

A2QGM4 Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: A2QGM4 · LSX · EUR · DE

A2QGM4:LSX represents Remegen Co. Ltd. Class A, a biopharmaceutical company focused on the development of innovative therapies for cancer treatment. The company is actively engaged in clinical trials and has been making headlines with its advancements in drug development. Recent filings and news updates highlight its commitment to expanding its product pipeline and addressing unmet medical needs in oncology. Investors can stay informed about upcoming events and market developments that may impact Remegen's growth trajectory.

A2QGM4:LSXEURDEUpdated July 21, 2026
Remegen Co. Ltd. Class A logo
Ticker
A2QGM4:LSX
Asset type
Stock
Market cap
$9.44B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Remegen Co. Ltd. Class A A2QGM4:LSX stock context

A2QGM4:LSX represents Remegen Co. Ltd. Class A, a biopharmaceutical company focused on the development of innovative therapies for cancer treatment. The company is actively engaged in clinical trials and has been making headlines with its advancements in drug development. Recent filings and news updates highlight its commitment to expanding its product pipeline and addressing unmet medical needs in oncology. Investors can stay informed about upcoming events and market developments that may impact Remegen's growth trajectory.

Research Remegen Co. Ltd. Class A

Alternate listings